Evidence map›Paper›PMID 41555046›Full record

ArticleNature materials2026

Cell viscosity influences haematogenous dissemination and metastatic extravasation of tumour cells.

Valentin Gensbittel, Zeynep Yesilata, Louis Bochler, Gautier Follain, Laurie Nemoz-Billet, Olivier Lefebvre, Klemens Uhlmann, Annabel Larnicol, Giulia E M Ammirati, Sébastien Harlepp and 16 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Valentin GensbittelTumor Biomechanics, INSERM UMRS 1109, Strasbourg, France.ORCID 0000-0001-7363-2218
Zeynep YesilataTumor Biomechanics, INSERM UMRS 1109, Strasbourg, France.
Louis BochlerTumor Biomechanics, INSERM UMRS 1109, Strasbourg, France.ORCID 0009-0003-7050-3287
Gautier FollainTumor Biomechanics, INSERM UMRS 1109, Strasbourg, France.ORCID 0000-0003-0495-9529
Laurie Nemoz-BilletTumor Biomechanics, INSERM UMRS 1109, Strasbourg, France.
Olivier LefebvreTumor Biomechanics, INSERM UMRS 1109, Strasbourg, France.
Klemens UhlmannChair of Continuum Mechanics, Ruhr-Universität Bochum, Bochum, Germany.
Annabel LarnicolTumor Biomechanics, INSERM UMRS 1109, Strasbourg, France.
Giulia E M AmmiratiDepartment of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.ORCID 0009-0008-5956-1052
Sébastien HarleppTumor Biomechanics, INSERM UMRS 1109, Strasbourg, France.ORCID 0000-0001-8891-7953
Ruchi GoswamiMax Planck Institute for the Science of Light & Max-Planck-Zentrum für Physik und Medizin, Erlangen, Germany.ORCID 0000-0001-9724-2898
Salvatore GirardoMax Planck Institute for the Science of Light & Max-Planck-Zentrum für Physik und Medizin, Erlangen, Germany.ORCID 0000-0002-5350-0186
Laetitia PaulenTumor Biomechanics, INSERM UMRS 1109, Strasbourg, France.
Vincent HyenneTumor Biomechanics, INSERM UMRS 1109, Strasbourg, France.
Vincent MittelheisserTumor Biomechanics, INSERM UMRS 1109, Strasbourg, France.
Tristan StemmelenUniversité de Strasbourg, Strasbourg, France.
Anne MolitorUniversité de Strasbourg, Strasbourg, France.
Raphael CarapitoUniversité de Strasbourg, Strasbourg, France.
Guillaume BelthierInstitut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France.ORCID 0000-0002-4857-0008
Julie PannequinInstitut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France.ORCID 0000-0002-9956-373X
Martin KräterMax Planck Institute for the Science of Light & Max-Planck-Zentrum für Physik und Medizin, Erlangen, Germany.ORCID 0000-0001-7122-7331
Daniel J MüllerDepartment of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.ORCID 0000-0003-3075-0665
Daniel BalzaniChair of Continuum Mechanics, Ruhr-Universität Bochum, Bochum, Germany.ORCID 0000-0002-1422-4262
Jochen GuckMax Planck Institute for the Science of Light & Max-Planck-Zentrum für Physik und Medizin, Erlangen, Germany. dorothe.burggraf@mpl.mpg.de.ORCID 0000-0002-1453-6119
Naël OsmaniTumor Biomechanics, INSERM UMRS 1109, Strasbourg, France. osmani@unistra.fr.ORCID 0000-0003-1195-753X
Jacky G GoetzTumor Biomechanics, INSERM UMRS 1109, Strasbourg, France. jacky.goetz@inserm.fr.ORCID 0000-0003-2842-8116

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastases arise from a multistep process during which tumour cells face several microenvironmental mechanical challenges, which influence metastatic success. However, how circulating tumour cells (CTCs) adapt their mechanics to such microenvironments is not fully understood. Here we report that the deformability of CTCs affects their haematogenous dissemination and identify mechanical phenotypes that favour metastatic extravasation. Combining intravital microscopy with CTC-mimicking elastic beads, mechanical tuning in tumour lines and profiling of tumour-patient-derived cells, we demonstrate that the inherent mechanical properties of circulating objects dictate their ability to enter constraining vessels. We identify cellular viscosity as a rheostat of CTC circulation and arrest, and show that cellular viscosity is crucial for efficient extravasation. Moreover, we find that mechanical properties that favour extravasation and subsequent metastatic outgrowth can be opposite. Altogether, our results establish CTC viscosity as a key biomechanical parameter that shapes several steps of metastasis.

Indexed as

Neoplastic Cells, CirculatingAnimalsCell Line, TumorHumansMiceNeoplasm MetastasisTumor MicroenvironmentViscosity

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.